Certificate Course in Management of Thyroid Disorders
This course is Accredited by the South Asian Federation of Endocrine Societies SAFES (2016-17) & Endorsed by Asia & Oceania Thyroid Association - AOTA (2016-25)
Thyroid disorders are the commonest among all the endocrine diseases worldwide. The
situation holds true for India as well, where it has been estimated that about 42 million
people suffer from thyroid disorders.
In India, the entire population is prone to iodine deficiency disorders (IDD) due to
deficiency of iodine in the soil of the subcontinent. The National Iodine Deficiency
Disorders Control Program (NIDDCP), with the key component of universal salt
iodization, has been operational in India for more than two decades. Yet, the overall
prevalence of IDD continues to be more than 10% in the country. A recent study
conducted in school children across schools in India observed that endemic goiter in
school children persisted nationwide despite best efforts of the program.
Hypothyroidism is a common disorder in India, and over the years its incidence seems to
rising. A landmark multi-center study in eight major cities of India noted hypothyroidism
to be prevalent among 10.95% of the adult population. It was thrice as common in
females as compared to males. A recent study across 11 cities in nine states of India
reported a prevalence as high as 13.13% of hypothyroidism in pregnancy. Congenital
hypothyroidism is a critical variant of hypothyroidism. As compared to a worldwide
average value of 1 in 3,800 subjects, in India the disease has been reported to occur at
a higher rate of 1 in every 2,640 newborns.
Hyperthyroidism, though not as common as hypothyroidism, is still quite prevalent. In
the above-mentioned eight-city study, the prevalence of thyrotoxicosis was found to be
0.72% among the adult population, with subclinical hyperthyroidism almost twice as
common at 1.27%.
Thyroid cancer data available from the cancer registries reveals a prevalence of
0.1%-0.2%. The age-adjusted incidence rates of thyroid cancer per 100,000 were about
1 for males and 1.8 for females as per the Mumbai Cancer Registry, which covered a
population of 9.81 million subjects.
To enhance knowledge, skills and core competencies of primary care physicians to address case management, counselling, referral and prevention of thyroid disorders in patients.
To build a network of physicians across the country, to enable early diagnosis and prompt referrals of patients and establish a referral linkage pattern.
CCMTD is an executive on-job training program in which PCPs, are provided training in various Regional Training Centres spread all across India. Total duration of the course is four months with once a month contact session, conducted on a designated weekends to better suit the busy practice schedule of physicians.
MD/DNB (Medicine or Internal Medicine or Family Medicine)
Or
MBBS with minimum 3 years of clinical experience
The course utilizes a variety of teaching/learning techniques. Training in thyroid disorders management is complemented by providing the participants with various distinguish case studies, activities and assignments. The course is offered on a modular basis with judicious mix of case studies, group discussion, clinical videos and direct teaching by eminent expert in the field of Endocrinology with great flexibility to accommodate participant's requirements.
Certificate Course in Management of Thyroid Disorders is a joint certification by Public Health Foundation of India (PHFI) and Chellaram Diabetes Institute (CDI), Pune supported with an educational grant from GlaxoSmithKline Pharmaceuticals Limited, India. The primary objective of the course is to enhance knowledge, skills and core competencies of primary care physicians in management of thyroid disorders for better patient outcome and establishing robust referral linkages. It's a once a month contact session, which will be conducted on designated weekend at regional centers across India.
The Public Health Foundation of India (PHFI) is a public private initiative that has collaboratively evolved through consultations with multiple constituencies including Indian and International academia, state and central governments, multi & bi-lateral agencies and civil society groups. PHFI is a response to redress the limited institutional capacity in India for strengthening training, research and policy development in the area of Public Health. Structured as an independent foundation, PHFI adopts a broad, integrative approach to public health, tailoring its endeavors to Indian conditions and bearing relevance to countries facing similar challenges and concerns. The PHFI focuses on broad dimensions of public health that encompass promotive, preventive and therapeutic services, many of which are frequently lost sight during policy planning as well as in popular understanding. Honorable 14th Prime Minister of India Dr. Manmohan Singh, launched PHFI on 28th March, 2006 at New Delhi. PHFI recognizes the fact that meeting the shortfall of health professionals is imperative to a sustained and holistic response to the public health concerns in the country which in turn requires health care to be addressed not only from the scientific perspective of what works, but also from the social perspective of, who needs it the most. For more information on activities at PHFI, visit www.phfi.org
Chellaram Diabetes Institute (CDI) is a unit of the Chellaram Foundation founded by Mr Lal L Chellaram. CDI is a not-for-profit organization based in Pune with the principal objective of creating a lasting impact on Diabetes in India as well as globally. This vision is intended to be achieved through four pillars, viz. patient care, education, research and awareness. In addition, CDI operates an ambitious rural outreach program, which combines all the four pillars, to the doorstep of the underprivileged rural population. CDI operates a state-of-the-art Diabetes centre in Pune, which is equipped to provide comprehensive care under one roof for Diabetes and its complications. With the conviction that education is one of the most effective tools influencing Diabetes care, CDI has designed and conducted several training programs for doctors, nurses and paramedical staff, as well as for community health workers. CDI strives to research the cause of high prevalence of Diabetes among Indians, and promote measures to prevent or delay the onset of Diabetes and its complications, thereby creating a lasting impact on Diabetes. Through clinical care, research as well as education, CDI hopes to make a mark in the field of other endocrine disorders like thyroid disorders as well. Dr. Unnikrishnan AG, CEO and Chief Endocrinologist at CDI, and his team have prepared the draft content of the course. For more information visit: www.cdi.org.in
GSK is the Educational grant support partner for the CCMTD. It was established in the year 1924 in India, GlaxoSmithKline Pharmaceuticals Limited in India is one of the oldest pharmaceuticals company. It is a leading, research-based healthcare and pharmaceutical company. The company is the market leader in most of the therapeutic categories in which it operates. GSK also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others. GSK has two manufacturing units in India, located at Nashik and Thane as well as a clinical development centre in Bangalore. At GSK, Corporate Social Responsibility program works towards fulfilling basic healthcare, education and other developmental needs of the underserved population.
The Panel of National Experts for CCMTD Cycle III includes 15 renowned eminent endocrinologists of the country. The panel acts as an advisory body for course content, curriculum review & finalizing the course modalities.
Regional Faculty are prominent Endocrinologists/Diabetologists in their respective regions, they provide training to enrolled candidates in various regional training centres all across India with trainer to participant ratio of approx. 1:20.
Participants are Primary Care Physicians (PCPs) who wish to enhance their skills to address case management, counselling, referral and prevention of thyroid disorders. They are MBBS Doctors with minimum of 3 years experience working in both private and public sector. Forty five (45%) of the participants who have obtained the training so far are Post-Graduates Doctors.
Observers are public health specialists or hospital administrators (faculty of community medicine or hospital administration) from various medical institutions of India as well as representatives from PHFI. They ensures quality of conduct of contact sessions
The Panel of National Experts for CCMTD Cycle III includes 15 renowned eminent endocrinologists of the country. The panel acts as an advisory body for course content, curriculum review & finalizing the course modalities.
Regional Faculty are prominent Endocrinologists/Diabetologists in their respective regions, they provide training to enrolled candidates in various regional training centres all across India with trainer to participant ratio of approx. 1:20
Observers are public health specialists or hospital administrators (faculty of community medicine or hospital administration) from various medical institutions of India as well as representatives from PHFI. They ensures quality of conduct of contact sessions
Participants are Primary Care Physicians (PCPs) who wish to enhance their skills to address case management, counselling, referral and prevention of thyroid disorders. They are MBBS Doctors with minimum of 3 years experience working in both private and public sector. Forty five (45%) of the participants who have obtained the training so far are Post-Graduates Doctors
-Dr.-R.K.-Marwaha-.png)
For latest updates on the upcoming cycle, simply enter your details in the form below.
By registering, you agree to receive communications about the all updates
*Fields marked are mandatory.